These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 23886171)
21. The prognostic role of RASSF1A promoter methylation in breast cancer: a meta-analysis of published data. Jiang Y; Cui L; Chen WD; Shen SH; Ding LD PLoS One; 2012; 7(5):e36780. PubMed ID: 22615811 [TBL] [Abstract][Full Text] [Related]
22. Hypermethylation of RASSF1A and BLU tumor suppressor genes in non-small cell lung cancer: implications for tobacco smoking during adolescence. Marsit CJ; Kim DH; Liu M; Hinds PW; Wiencke JK; Nelson HH; Kelsey KT Int J Cancer; 2005 Mar; 114(2):219-23. PubMed ID: 15540210 [TBL] [Abstract][Full Text] [Related]
23. Association between cigarette smoking and RASSF1A gene promoter hypermethylation in lung cancer patients: a meta- analysis. Wu XM; Chen Y; Shao Y; Zhou XL; Tang WR Asian Pac J Cancer Prev; 2014; 15(19):8451-4. PubMed ID: 25339045 [TBL] [Abstract][Full Text] [Related]
24. Predictive value of unmethylated RASSF1A on disease progression in non-small cell lung cancer patients receiving pemetrexed-based chemotherapy. Deng Q; Su B; Ji X; Fang Q; Zhou S; Zhou C Cancer Biomark; 2020; 27(3):313-323. PubMed ID: 31839603 [TBL] [Abstract][Full Text] [Related]
25. RASSF1A promoter methylation is associated with increased risk of thyroid cancer: a meta-analysis. Shou F; Xu F; Li G; Zhao Z; Mao Y; Yang F; Wang H; Guo H Onco Targets Ther; 2017; 10():247-257. PubMed ID: 28123306 [TBL] [Abstract][Full Text] [Related]
26. Expression of Delta DNMT3B variants and its association with promoter methylation of p16 and RASSF1A in primary non-small cell lung cancer. Wang J; Walsh G; Liu DD; Lee JJ; Mao L Cancer Res; 2006 Sep; 66(17):8361-6. PubMed ID: 16951144 [TBL] [Abstract][Full Text] [Related]
27. Association between RASSF1A promoter methylation and renal cell cancer susceptibility: a meta-analysis. Huang YQ; Guan H; Liu CH; Liu DC; Xu B; Jiang L; Lin ZX; Chen M Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173228 [TBL] [Abstract][Full Text] [Related]
28. Association between P(16INK4a) promoter methylation and non-small cell lung cancer: a meta-analysis. Gu J; Wen Y; Zhu S; Hua F; Zhao H; Xu H; You J; Sun L; Wang W; Chen J; Zhou Q PLoS One; 2013; 8(4):e60107. PubMed ID: 23577085 [TBL] [Abstract][Full Text] [Related]
29. Promoter methylation of the RASSF1A gene may contribute to colorectal cancer susceptibility: a meta-analysis of cohort studies. Wang HL; Liu P; Zhou PY; Zhang Y Ann Hum Genet; 2014 May; 78(3):208-16. PubMed ID: 24621386 [TBL] [Abstract][Full Text] [Related]
30. Aberrant methylation of RASGRF2 and RASSF1A in human non-small cell lung cancer. Chen H; Suzuki M; Nakamura Y; Ohira M; Ando S; Iida T; Nakajima T; Nakagawara A; Kimura H Oncol Rep; 2006 May; 15(5):1281-5. PubMed ID: 16596198 [TBL] [Abstract][Full Text] [Related]
31. Association of RASSF1A and p63 with poor recurrence-free survival in node-negative stage I-II non-small cell lung cancer. Ko E; Lee BB; Kim Y; Lee EJ; Cho EY; Han J; Shim YM; Park J; Kim DH Clin Cancer Res; 2013 Mar; 19(5):1204-12. PubMed ID: 23319821 [TBL] [Abstract][Full Text] [Related]
32. RASSF1A promoter methylation was associated with the development, progression and metastasis of cervical carcinoma: a meta-analysis with trial sequential analysis. Zheng F; Yu H Arch Gynecol Obstet; 2018 Feb; 297(2):467-477. PubMed ID: 29288321 [TBL] [Abstract][Full Text] [Related]
33. RASSF1A promoter methylation and Kras2 mutations in non small cell lung cancer. Li J; Zhang Z; Dai Z; Popkie AP; Plass C; Morrison C; Wang Y; You M Neoplasia; 2003; 5(4):362-6. PubMed ID: 14511407 [TBL] [Abstract][Full Text] [Related]
34. DNA methylation markers and early recurrence in stage I lung cancer. Brock MV; Hooker CM; Ota-Machida E; Han Y; Guo M; Ames S; Glöckner S; Piantadosi S; Gabrielson E; Pridham G; Pelosky K; Belinsky SA; Yang SC; Baylin SB; Herman JG N Engl J Med; 2008 Mar; 358(11):1118-28. PubMed ID: 18337602 [TBL] [Abstract][Full Text] [Related]
35. Association of RASSF1A hypermethylation with risk of HBV/HCV-induced hepatocellular carcinoma: A meta-analysis. Peng JL; Wu JZ; Li GJ; Wu JL; Xi YM; Li XQ; Wang L Pathol Res Pract; 2020 Oct; 216(10):153099. PubMed ID: 32853942 [TBL] [Abstract][Full Text] [Related]
36. Relationship of Ras association domain family 1 methylation and K-ras mutation in primary non-small cell lung cancer. Kim DH; Kim JS; Park JH; Lee SK; Ji YI; Kwon YM; Shim YM; Han J; Park J Cancer Res; 2003 Oct; 63(19):6206-11. PubMed ID: 14559805 [TBL] [Abstract][Full Text] [Related]
37. Frequent epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in non-small-cell lung cancer. Zhang Y; Miao Y; Yi J; Wang R; Chen L Clin Lung Cancer; 2010 Jul; 11(4):264-70. PubMed ID: 20630829 [TBL] [Abstract][Full Text] [Related]
38. Association of RASSF1A promoter methylation with gastric cancer risk: a meta-analysis. Shi DT; Han M; Gao N; Tian W; Chen W Tumour Biol; 2014 Feb; 35(2):943-8. PubMed ID: 23982879 [TBL] [Abstract][Full Text] [Related]
39. Association between MGMT promoter methylation and non-small cell lung cancer: a meta-analysis. Gu C; Lu J; Cui T; Lu C; Shi H; Xu W; Yuan X; Yang X; Huang Y; Lu M PLoS One; 2013; 8(9):e72633. PubMed ID: 24086261 [TBL] [Abstract][Full Text] [Related]
40. Does adenomatous polyposis coli gene promoter 1A methylation increase non-small cell lung cancer risk? A meta-analysis. Hu B; Zhang H; Wei H; Wang Z; Zhang F; Wang X; Li L Thorac Cancer; 2017 Sep; 8(5):410-416. PubMed ID: 28497891 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]